Skip to main content

Table 1 Baseline characteristics of total cohort and by overall mortality

From: Fifteen-year experience with pericardiectomy at a tertiary referral center

  Total
(n = 63)
Alive
(n = 47)
Dead
(n = 16)
p-value
Age, years 55.62 ± 14.27 54.79 ± 14.51 58.06 ± 13.69 0.6525
Body Mass Index 31.23 ± 8.31 32.3 ± 8.46 28.08 ± 7.21 0.0511
Gender     0.961
 Male 43 (68.25) 32 (68.09) 11 (68.75)  
 Female 20 (31.75) 15 (31.91) 5 (31.25)  
Race     0.681
 White 54 (85.71) 41 (87.23) 13 (81.25)  
 Non-White 9 (14.29) 6 (12.77) 3 (18.75)  
Risk Factors
 Congestive Heart Failure 57 (90.48) 42 (89.36) 15 (93.75) > 0.999
 Prior Cardiac Intervention 29 (46.03) 18 (38.30) 11 (68.75) 0.035
 Prior Radiation Exposure 6 (9.52) 3 (6.38) 3 (18.75) 0.166
 Hypertension 50 (79.37) 36 (76.60) 14 (87.50) 0.486
 Liver Disease 15 (23.81) 12 (25.53) 3 (18.75) 0.740
 COPDa 16 (25.40) 11 (23.40) 5 (31.25) 0.533
 Pneumonia 15 (23.81) 12 (25.53) 3 (18.75) 0.740
 Diabetes 19 (30.16) 14 (29.79) 5 (31.25) 0.912
 Dyslipidemia 35 (55.56) 26 (55.32) 9 (56.25) 0.948
 CKDb - Dialysis 10 (15.87) 4 (8.51) 6 (37.50) 0.013
 CKDb - No Dialysis 11 (17.46) 9 (19.15) 2 (12.50) 0.714
 Coronary Artery Disease 21 (33.33) 15 (31.91) 6 (37.50) 0.682
 Atrial Fibrillation 19 (30.16) 15 (31.91) 4 (25.00) 0.757
 Hypothyroidism 13 (20.63) 11 (23.40) 2 (12.50) 0.486
 Prior Kidney Transplant 3 (4.76) 2 (4.26) 1 (6.25) > 0.999
 Autoimmune Disease 8 (12.70) 6 (12.77) 2 (12.50) > 0.999
 Illicit Drug Use 8 (12.70) 7 (14.89) 1 (6.25) 0.667
 Immunocompromised 10 (15.87) 5 (10.64) 5 (31.25) 0.051
 Pericardial Effusion 34 (53.97) 24 (51.06) 10 (62.50) 0.428
 Prior Pericardiocentesis 11 (17.46) 8 (17.02) 3 (18.75) > 0.999
 Prior Pericardial Window 11 (17.46) 7 (14.89) 4 (25.00) 0.448
 Pleural Effusion 23 (36.51) 14 (29.79) 9 (56.25) 0.058
 Redo Sternotomy 9 (14.29) 4 (8.51) 5 (31.25) 0.039
 LVEFc 54.48 ± 10.70 54.53 ± 10.06 54.31 ± 12.97 0.8792
Reason for Surgery     0.217
 Constrictive Pericarditis 50 (79.37) 36 (76.60) 14 (87.50)  
 Hemorrhagic Pericarditis 6 (9.52) 6 (12.77) 0  
 Recurrent Pericardial Effusion 4 (6.35) 2 (4.26) 2 (12.50)  
 Pyopericardium 3 (4.76) 3 (6.38) 0  
NYHAd Class on Admission     0.386
 I 6 (9.52) 6 (12.77) 0  
 II 21 (33.33) 16 (34.04) 5 (33.33)  
 III 27 (42.86) 20 (42.55) 7 (46.67)  
 IV 7 (11.11) 4 (8.51) 3 (20.00)  
 Not Available 2 (3.17) 1 (2.13) 1 (6.25)  
Presenting Symptoms
 Fever 5 (7.94) 4 (8.51) 1 (6.25) > 0.999
 Nausea 5 (7.94) 5 (10.64) 0 0.317
 Dyspnea 57 (90.48) 41 (87.23) 16 (100.00) 0.324
 Fatigue 55 (87.30) 40 (85.11) 15 (93.75) 0.667
 Lower Extremity Edema 36 (57.14) 26 (55.32) 10 (62.50) 0.616
 Chest Pain 31 (49.21) 23 (48.94) 8 (50.00) 0.941
 Abdominal Distension 30 (47.62) 22 (46.81) 8 (50.00) 0.825
 Creatinine, mg/dL 1.09 (0.66) 1.01 (0.61) 1.5 (1.21) 0.0067
Medical Management
 Diuretics 41 (65.08) 32 (68.09) 9 (56.25) 0.391
 NSAIDe 23 (36.51) 19 (40.43) 4 (25.00) 0.371
 Colchicine 5 (7.94) 5 (10.64) 0 0.317
Intraop Variables
 Procedure Performed     0.222
  Isolated Pericardiectomy 42 (66.67) 29 (61.70) 13 (81.25)  
  Pericardectomy + Concomitant Procedure 21 (33.33) 18 (38.30) 3 (18.75)  
CPBf utilization 23 (36.51) 20 (42.55) 3 (18.75) 0.133
CPB time, minutes 162 ± 89.96 153.28 ± 88.99 214.33 ± 93.93 0.247
Cross Clamp time, minutes 110.43 ± 82.55 107.5 ± 81.70 128 ± 120.21 > 0.999
 Status     0.038
  Elective 41 (65.08) 34 (72.34) 7 (43.75)  
  Urgent 22 (34.92) 13 (27.66) 9 (56.25)  
  1. Values are expressed as n(%) and mean + standard deviation unless otherwise noted
  2. achronic obstructive pulmonary disease
  3. bchronic kidney disease
  4. cleft ventricular ejection fraction
  5. dNew York Heart Association
  6. enon-steroidal anti-inflammatory drug
  7. fcardiopulmonary bypass